Sorry if it is confusing ,
my example of one dose of 350
Sorry if it is confusing ,
my example of one dose of 350 mg will give 17,500 tests was just to show how small amount they need for a test. And for 350 mg they will make 7,000,000.00 doll total if 400.00 per test , of course our part will be some % of it ...
I believe that between HIV and all metastatic cancers , test will be extremely busy , maybe not the first month , but good revenue will happen here soon..
Now when the talk is about metastatic cancers and CCR5 , every patient with it will be tested...
If you look at Merck information , they have CCR5 at the top of cancer talk.
Pfizer only will need it a lot for its Maraviroc.
IMO , very important news today.
CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Top 5 Most Recently Viewed Articles
Devon Energy's Impressive Financial Growth Over Five Years Devon Energy (NASDAQ: DVN) has showcased remarkable performance over the last five years, outpacing the market by an annualized rate of 7.87%. This stellar achievement translates to an average annual return of 21.41%, underscoring its position as a formidable player in the energy sector. A Look at Past Investments...
Continue Reading
TLG IMMOBILIEN AG's Tender Offer Overview TLG IMMOBILIEN AG, a notable player in the real estate sector, has officially announced a public delisting tender offer for the shareholders of WCM Beteiligungs- und Grundbesitz-Aktiengesellschaft. This offer not only marks a significant step in TLG's strategic acquisitions but also serves to streamline WCM's ownership structure....
Continue Reading
Boss Energy Strengthens Its Position via Share Acquisition Boss Energy Limited (BQSSF) has recently made significant strides in expanding its investment portfolio. The company has entered into a share purchase agreement to acquire 23,500,000 common shares of Laramide Resources Ltd. This acquisition reflects Boss Energy's strategic move to enhance its holdings in the...
Continue Reading
TD SYNNEX Achieves Top Score for LGBTQ+ Workplace Equality TD SYNNEX (NYSE: SNX) has received a remarkable recognition for its strong commitment to inclusivity and diversity by scoring 100 on the Human Rights Campaign Foundation's 2024-2025 Corporate Equality Index. This index is a valued benchmark that assesses corporate policies and practices regarding LGBTQ+ workplace...
Continue Reading
Revolutionizing Data Handling with Hyland's Knowledge Enrichment Hyland is leading the charge in the enterprise content management landscape with its latest innovation. The introduction of Knowledge Enrichment to its Content Innovation Cloud is a game changer, aiming to enhance how unstructured data is utilized to support artificial intelligence (AI) and automation. This...
Continue Reading
